官方服务：
资源简介：
Construct validity of the C-RC-QOL.
应用场景：
创建时间：
2018-11-08
相关数据集
OPHTHALMIC FORMULATIONS AND USES THEREOF
The present invention provides a reproxalap ophthalmic solution， and methods of using the same for treating a disease or disorder such as allergic conjunctivitis.
国家林业和草原科学数据中心2023-02-12 更新90
Data_Sheet_6_Ovalbumin-Induced Allergic Inflammation Diminishes Cross-Linked Collagen Structures in an Experimental Rabbit Model of Corneal Cross-Linking.ZIP
BackgroundAllergic conjunctivitis (AC) is one of the reported potential risk factors of progression in keratoconus patients after corneal cross-linking surgery; however, the causal relationship is sti
NIAID Data Ecosystem70
North America Acute and Chronic Allergic Conjunctivitis Treatment Market
The report on North America Acute and Chronic Allergic Conjunctivitis Treatment covers a summarized study of several factors supporting market growth, such as market size, market type, major regions,
IMR REPORTS30
Phase 3 QoL scales scoping review data extraction
Phase 2 QoL data extraction for scoping review.
Figshare2023-08-25 更新80
Subject (visual impairment in the worse eye) characteristics and EQ-5D /VAS index scores.
Data are presented as the means ± SE, or % (SE) * KNHNES participants † Estimated number of the Korean population aged ≥19. VI: Visual impairment, EQ-5D: EuroQol five-dimensional questionnaire, EQ-VAS
NIAID Data Ecosystem40
